n(1)-methylnicotinamide has been researched along with concanavalin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chlopicki, S; Czarnowska, E; Jakubowski, A; Jasztal, A; Kaminski, K; Sitek, B; Slominska, EM; Smolenski, RT; Sternak, M; Szafarz, M; Walczak, M; Wojcik, T | 1 |
Amiya, T; Chu, PS; Ebinuma, H; Fukuda, S; Kanai, T; Katayama, T; Mikami, Y; Miyake, R; Nakamoto, N; Shiba, S; Suzuki, T; Taniki, N; Teratani, T; Tsukimi, T; Yamaguchi, A | 1 |
2 other study(ies) available for n(1)-methylnicotinamide and concanavalin a
Article | Year |
---|---|
Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
Topics: Acute-Phase Reaction; Aldehyde Oxidase; Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Energy Metabolism; Hepatitis; Hepatocytes; Interleukin-6; Liver Function Tests; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Niacinamide; Nicotinamide N-Methyltransferase | 2015 |
Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.
Topics: Animals; Chemical and Drug Induced Liver Injury; Colitis; Concanavalin A; Dextran Sulfate; Disease Models, Animal; Female; Gastrointestinal Microbiome; Hepatitis; Interleukin-10; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Niacinamide; T-Lymphocytes | 2018 |